Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
We contrast TRI with price indices, highlighting dividends, corporate actions, and reinvestment assumptions that shape different performance pictures.
24,487 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
BlackRock's Larry Fink presents two stark paths for oil and markets tied to the Iran conflict, challenging households...
AI stocks have pulled back from recent highs, but patient investors can uncover solid opportunities. This guide expla...
A bold alliance between Allseas and a mining innovator aims to commercialize deep-sea nodule recovery. This strategic...
ICP bucked a broad market downturn, edging higher while Bitcoin and Ethereum slumped. On-chain metrics and ecosystem ...
Marvell Technology joins the S&P 500, a move that can boost liquidity and attract index funds. But does that translat...
As inflation remains stubborn, Bank of America nudges its rate outlook higher, forecasting three quarter-point Fed hi...
A memory stock that looked ordinary just a year ago has stunned investors with an 8x move. Now Wall Street is unanimo...
As rates move and markets shift in 2026, investors weigh three paths to generate $18,000 a year from a $1,500-a-month...
New Realtor.com analysis finds starter home inventory trails pre-pandemic levels by roughly 300,000 listings, with en...
A widening split on who can afford a home is reshaping the housing landscape. This article breaks down why the divide...
MercadoLibre faced a sharp price move after a quarter that showed strong top-line momentum but weaker profitability. ...